Lista de obras -

Achieving target low‑density lipoprotein cholesterol levels in the Polish population

scientific article published on 01 January 2012

Assessment of medical students' intake of antioxidants and vitamins essential for homocysteine metabolism

artículo científico publicado en 2002

Changes in vitamins intake in overweight and obese adults after low-energy diets

artículo científico publicado en 2002

Clinical management of heterozygous familial hypercholesterolemia in a Polish outpatient metabolic clinic: a retrospective observational study

scientific article published on 30 November 2017

Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia

artículo científico publicado en 2005

Comment to article. Znaczenie prewencji w redukcji zgonów wieńcowych

artículo científico publicado el 1 de diciembre de 2010

Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.

artículo científico publicado en 2004

Current state-of-the-art knowledge on the role of omega-3 fatty acids in the prevention of cardiovascular disease

artículo científico publicado en 2020

Dietary calcium and obesity in men

scientific article published on 01 January 2007

Effect of a low-energy diet on body weight and dietary intake in women after one year treatment

artículo científico publicado en 2008

Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease

artículo científico publicado el 1 de julio de 2003

Homocysteine--is it still an important risk factor for cardiovascular disease?

artículo científico

How do we know that statins are diabetogenic, and why? Is it an important issue in the clinical practice?

scientific article published on 01 August 2018

How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors

artículo científico publicado en 2020

Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years

artículo científico publicado en 2019

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum

scientific article published on 01 January 2013

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum

artículo científico publicado en 2013

Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum

artículo científico publicado en 2013

Nutrition and lifestyle in patients pharmacologically treated due to hypertensionally treated due to hypertension

artículo científico publicado en 2016

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

artículo científico publicado en 2021

Polish Forum for Prevention Guidelines on Dyslipidaemia: update 2016

artículo científico publicado en 2017

Polish forum for prevention guidelines on diet

artículo científico publicado en 2008

Prevention of ischaemic heart disease in the elderly. Reduction of coronary risk factors

artículo científico publicado el 1 de abril de 2003

Primary prevention of cardiovascular disease and other chronic noncommunicable diseases in the centre of attention of the United Nations: special importance of a prudent diet.

artículo científico publicado en 2013

Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement

artículo científico publicado en 2016

Statins 25 years in preventive cardiology

artículo científico publicado el 1 de enero de 2012

The HDL paradox: what does it mean and how to manage low serum HDL cholesterol level?

artículo científico

The association between the insertion/deletion polymorphism of the angiotensin converting enzyme gene and hypertension, as well as environmental, biochemical and anthropometric factors

artículo científico publicado en 2020

Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates

artículo científico publicado en 2005

Vitamins and minerals intake in hyperlipidemic outpatients

scientific article published on 01 January 2005

What do we know about lipoprotein(a)?

artículo científico

What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?

scientific article published on 08 April 2020

What does obesity paradox mean in coronary heart disease?

artículo científico publicado en 2013

What is the future for niacin after the AIM-HIGH study?

artículo científico publicado el 1 de enero de 2012

[Antioxidant vitamins status in patients with combined hyperlipidemia]

artículo científico publicado en 2005

[CETP gene TaqIB polymorphism and plasma lipids in patients with overweight and obesity]

artículo científico publicado en 2012

[Calcium intake and glucose and lipids concetrations in overweight and obese patients]

artículo científico publicado en 2007

[Effect of a low-energy diet on body weight and body composition after one year treatment]

artículo científico publicado en 2006

[Effectiveness of omega 3 fatty acids in ischaemic heart disease prevention]

artículo científico publicado en 2005

[Fatty acids intake and serum lipids profile in overweighted and obese adults]

scientific article published on 01 January 2012

[Low-carbohydrate, high-fat diets: efficacy and safety]

artículo científico publicado en 2004

[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]

scientific article published on 01 January 2013

[Metabolic syndrome as a coronary risk factor. Prevention and treatment]

scientific article published on 01 July 2003

[New European guidelines on cardiovascular disease prevention in relation to the situation in Poland]

artículo científico publicado en 2004

Lista de obras de

Achieving target low‑density lipoprotein cholesterol levels in the Polish population

Assessment of medical students' intake of antioxidants and vitamins essential for homocysteine metabolism

Changes in vitamins intake in overweight and obese adults after low-energy diets

Clinical management of heterozygous familial hypercholesterolemia in a Polish outpatient metabolic clinic: a retrospective observational study

Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia

Comment to article. Znaczenie prewencji w redukcji zgonów wieńcowych

Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.

Current state-of-the-art knowledge on the role of omega-3 fatty acids in the prevention of cardiovascular disease

Dietary calcium and obesity in men

Effect of a low-energy diet on body weight and dietary intake in women after one year treatment

Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease

Homocysteine--is it still an important risk factor for cardiovascular disease?

How do we know that statins are diabetogenic, and why? Is it an important issue in the clinical practice?

How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors

Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum

Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum

Nutrition and lifestyle in patients pharmacologically treated due to hypertensionally treated due to hypertension

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

Polish Forum for Prevention Guidelines on Dyslipidaemia: update 2016

Polish forum for prevention guidelines on diet

Prevention of ischaemic heart disease in the elderly. Reduction of coronary risk factors

Primary prevention of cardiovascular disease and other chronic noncommunicable diseases in the centre of attention of the United Nations: special importance of a prudent diet.

Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement

Statins 25 years in preventive cardiology

The HDL paradox: what does it mean and how to manage low serum HDL cholesterol level?

The association between the insertion/deletion polymorphism of the angiotensin converting enzyme gene and hypertension, as well as environmental, biochemical and anthropometric factors

Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates

Vitamins and minerals intake in hyperlipidemic outpatients

What do we know about lipoprotein(a)?

What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?

What does obesity paradox mean in coronary heart disease?

What is the future for niacin after the AIM-HIGH study?

[Antioxidant vitamins status in patients with combined hyperlipidemia]

[CETP gene TaqIB polymorphism and plasma lipids in patients with overweight and obesity]

[Calcium intake and glucose and lipids concetrations in overweight and obese patients]

[Effect of a low-energy diet on body weight and body composition after one year treatment]

[Effectiveness of omega 3 fatty acids in ischaemic heart disease prevention]

[Fatty acids intake and serum lipids profile in overweighted and obese adults]

[Low-carbohydrate, high-fat diets: efficacy and safety]

[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]

[Metabolic syndrome as a coronary risk factor. Prevention and treatment]

[New European guidelines on cardiovascular disease prevention in relation to the situation in Poland]

What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?